발행물
컨퍼런스
제10회 재생불량빈혈연구회 심포지엄
2020
,
ASH 2019 guideline for ITP
61st ASH annual meeting and exposition
2019
Prognostic implication of inflammatory factor-based staging sytem in multiple myeloma in the new agent era
17th International myeloma workshop
The comparison of carfilzomib and dexamethasone versus pomalidomide-based combination chemotherapy after a 2nd-line therapy in relapsed and refractory multiple myeloma patients
제36차 한국혈전지혈학회 추계학술대회
Who should get long-term anticoagulant therapy using DOACs for VTE
대한심장학회 심장-종양학 연구회 심포지움
Analysis of carfilzomib cardiovascular safety profile in relapsed/refractory multiple myeloma